Xuezhi Feng | Marine Engineering Geology | Best Researcher Award

Posted on by The Scientist

Dr. Xuezhi Feng | Marine Engineering Geology | Best Researcher Award

Dr. Xuezhi Feng, Ocean University of China/Shandong Institute of Ecology and Environment, China

Dr. Xuezhi Feng is an Associate Professor at the Shandong Institute of Ecology and Environment, affiliated with the Ocean University of China. His expertise lies in marine geological engineering, environmental geotechnical engineering, and the ecological and environmental impacts of marine sediment processes. As a Youth Editorial Board Member of the Journal of Marine Environmental Engineering, he contributes significantly to the advancement of marine science research. With an impressive record of publications, patents, and research projects, Dr. Feng is recognized for integrating rigorous scientific methodology with innovative environmental solutions to address pressing marine ecological challenges.

Professional Profile

Scopus Profile | ORCID

Education

Dr. Feng earned his doctoral degree in Marine Geological Engineering from the Ocean University of China, where he developed a strong foundation in sedimentology, marine geotechnics, and coastal ecological assessment. His doctoral research integrated field observations, laboratory analyses, and modeling approaches to examine sediment transport dynamics and their environmental consequences. Through advanced coursework and hands-on research, he mastered critical methodologies such as sediment core sampling, geochemical profiling, and hydrodynamic modeling. His academic journey fostered a multidisciplinary approach that bridges engineering, marine science, and environmental sustainability. This background has enabled him to address complex coastal and offshore engineering problems with scientific precision and applied relevance.

Experience

As an Associate Professor, Dr. Feng has been instrumental in leading and managing research initiatives at the Shandong Institute of Ecology and Environment. He has successfully completed multiple funded research projects and is currently engaged in work that bridges theoretical models with practical engineering applications. His expertise has been sought in consultancy and industry projects, where he has provided solutions to mitigate ecological impacts of coastal development and marine engineering activities. His contributions extend to environmental impact assessments, sediment stability analyses, and designing eco-friendly marine infrastructure. He has actively collaborated with government agencies and environmental bodies to develop policies and guidelines for sustainable marine and coastal management. Additionally, his role as a Youth Editorial Board Member has allowed him to mentor early-career researchers, review high-impact journal submissions, and promote high scientific standards in marine environmental engineering publications.

Research Focus

Dr. Fengโ€™s research centers on the intersection of marine geological engineering and environmental sustainability. His primary focus is on understanding the movement, transformation, and environmental effects of marine sediments, particularly in the context of coastal and offshore engineering projects. This includes studying sediment resuspension caused by natural forces such as tides and internal waves, as well as human interventions like dredging and construction. He examines how these processes influence water quality, benthic habitats, and coastal morphology. His work in environmental geotechnical engineering also addresses the stability of seabeds, prevention of coastal erosion, and the development of resilient marine structures. By integrating geotechnical principles with ecological considerations, he aims to design engineering solutions that minimize adverse impacts on marine ecosystems while enhancing coastal resilience.

Publication Top Notes

Title: Impact of Internal Solitary Waves on Marine Suspended Particulate Matter: A Review
Authors: Zhengrong Zhang; Xuezhi Feng; Xiuyao Fan; Yuchen Lin; Chaoqi Zhu
Summary: Reviews mechanisms by which internal solitary waves influence distribution of suspended particulate matter.

Title: Review of Research Progress on the Impact of Submarine Groundwater Discharge on Pockmark Formation and Evolution
Authors: Zhengrong Zhang; Hongxian Shan; Xuezhi Feng; Zhentian Jia; Long Jiang; Siming Wang; Chaoqi Zhu
Summary: Examines how submarine groundwater discharge processes contribute to pockmark development and morphological changes.

Title: Internal solitary waves in the Shenhu continental shelf slope break zone of the northern South China Sea generate benthic storms
Authors: Yonggang Jia; Xuezhi Feng; Chaoqi Zhu; Linsen Wang; Xiaolei Liu; Cong Hu; Hongwei Wang
Summary: Investigates internal solitary waves triggering benthic storms impacting seabed environments in Shenhu slope.

Title: Free fall penetration test the undrained shear strength of submarine sediments
Authors: Linsen Wang; Xuezhi Feng; Xianming Zhu; Chaoqi Zhu; Yongzheng Quan; Yonggang Jia
Summary: Evaluates submarine sediment shear strength using innovative free fall penetration testing techniques.

Title: The impact of internal solitary waves on deep-sea benthic organisms on the continental slope of the northern South China Sea
Authors: Xuezhi Feng; Linsen Wang; Chunsheng Ji; Hui Wang; Chaoqi Zhu; Yonggang Jia
Summary: Studies ecological effects of internal solitary waves on deep-sea benthic organisms and habitats.

Conclusion

Latifah Al Shammari | Pharmaceutical Sciences | Best Researcher Award

Posted on by The Scientist

Dr. Latifah Al Shammari | Pharmaceutical Sciences | Best Researcher Award

Assistant professor at University of Hafr Albatin, Saudi Arabiaย 

Dr. Latifah Al Shammari is an accomplished Assistant Professor at the University of Hafr Al Batin, specializing in Pharmacognosy and Nutraceuticals . She holds degrees from King Saud University and a Ph.D. from Charles University, Czech Republic . With extensive experience as a Consultant Pharmacist , she has served in leadership roles, including Supervisor of Pharmacy Services at the Ministry of Healthโ€™s King Khalid General Hospital . Dr. Latifah is passionate about medication safety, academic excellence, and community health promotion, having actively participated in numerous conferences and World Health Day events . Her research, spanning over a dozen publications in indexed journals , focuses on advancing natural product sciences and nutraceutical innovations. Recognized with multiple awards , including a Research Excellence Award from the Second Riyadh Health Cluster, she continues to inspire through her scholarship, dedication, and contributions to Saudi Arabiaโ€™s growing pharmaceutical research landscape.

Professional Profile

Google Scholar

Educationย 

Dr. Latifah Al Shammari began her academic journey with a Bachelorโ€™s degree in Pharmaceutical Sciences (Pharmacognosy) ย from King Saud University, Riyadh . Her passion for natural product chemistry and therapeutic applications led her to pursue a Masterโ€™s degree in the same specialization , where she honed her skills in bioactive compound isolation and pharmacological evaluation. Striving for global academic exposure, she earned her Ph.D. in Pharmacognosy and Nutraceuticalsย  from Charles University, Prague , a prestigious institution known for its rigorous scientific research. Throughout her education, she engaged in interdisciplinary studies combining botany , chemistry , and pharmacology, equipping her with the expertise to bridge traditional knowledge with modern therapeutic science. Her academic journey reflects a balance of strong foundational training and advanced research skills, enabling her to contribute meaningfully to the field of medicinal plant research, nutraceutical development, and pharmaceutical education, both locally and internationally .

Experienceย 

Dr.ย  Latifah Al Shammari career spans academia, healthcare leadership, and community health advocacy. She currently serves as an Assistant Professor at the University of Hafr Al Batin , where she teaches, mentors, and conducts research in Pharmacognosy and Nutraceuticals . Previously, she was a Consultant Pharmacist and Supervisor of Pharmacy Services at the Ministry of Healthโ€™s King Khalid General Hospital , overseeing medication safety and quality assurance. She has also worked as a Medication Safety Officer ย and media representative for the Pharmaceutical Care Department, promoting rational drug use and patient safety . Her dedication extends to public health education through participation in World Health Day initiatives ย and awareness campaigns. Over the years, she has built research collaborations, attended national and international conferences, and contributed significantly to pharmaceutical education and policy development. Her multidisciplinary experience blends research expertise with practical healthcare solutions, impacting both the academic and clinical sectors .

Research Interest

Dr. Latifah Al Shammari research is anchored in Pharmacognosy and Nutraceuticals , exploring bioactive compounds from natural sources and their therapeutic applications. She is deeply interested in isolating and characterizing plant-derived molecules , evaluating their pharmacological potential against chronic diseases, and developing nutraceutical formulations for preventive healthcare. Her studies integrate traditional medicinal knowledge with modern analytical techniques , aiming to create safe, effective, and sustainable alternatives to synthetic drugs. Additionally, she is passionate about medication safety , optimizing therapeutic outcomes while minimizing adverse effects. She actively explores functional foods, herbal pharmacology, and the role of natural compounds in immune modulation and antioxidant defense. Collaborating with multidisciplinary teams , she seeks to bridge the gap between traditional medicine and evidence-based clinical practice. Her research not only addresses scientific innovation but also contributes to global health goals , sustainability, and the advancement of Saudi Arabiaโ€™s pharmaceutical research ecosystem .

Award and Honor

Dr. Latifah Al Shammari dedication to research and community service has earned her multiple accolades. She received the Research Award from the Second Riyadh Health Cluster ย for her outstanding contributions to pharmaceutical sciences. Her excellence has been recognized with certificates of appreciation from King Saud University ย and the Ministry of Health , highlighting her commitment to education, clinical service, and patient safety. She has been honored at both local and international conferences ย for her impactful presentations and research findings in Pharmacognosy and Nutraceuticals . In addition, she has been acknowledged for her efforts in public health education , particularly during World Health Day events. These recognitions reflect her dual commitment to advancing scientific knowledge and promoting community well-being. Through her achievements, Dr. Latifah stands out as a role model for aspiring scientists, blending academic excellence with societal impact .

Research Skill

Dr. Latifah Al Shammari possesses a robust skill set in natural products research , including phytochemical extraction, isolation, and structural characterization using advanced analytical techniques such as chromatography and spectroscopy . She is proficient in designing and executing pharmacological assays to evaluate bioactivity, particularly antioxidant, antimicrobial, and anti-inflammatory properties . Her expertise extends to nutraceutical formulation , safety assessment, and quality control. She demonstrates strong scientific writing ย and has published multiple peer-reviewed articles in indexed journals . Additionally, she excels in literature review, data interpretation , and research project management. Her collaborative mindset has facilitated interdisciplinary partnerships, enhancing research impact and innovation. She is also experienced in academic teaching, mentoring graduate students , and presenting at international conferences . Combining technical precision with creative problem-solving, Dr. Latifah continues to contribute to advancing pharmacognosy, nutraceutical development, and evidence-based herbal medicine .

Publication Top Notes

Title: Chemical composition and antimicrobial activity of the essential oil and lipid content of Carduus pycnocephalus L. growing in Saudi Arabia
Authors: L.A. Al-Shammari, W.H.B. Hassan, H.M. Al-Youssef
Journal: Journal of Chemical and Pharmaceutical Research, 4 (2), 1281-1287
Year: 2012
Cited by: 33

Title: Amaryllidaceae alkaloids from Hippeastrum x hybridum cv. Ferrari, and preparation of vittatine derivatives as potential ligands for Alzheimerโ€™s disease
Authors: L. Al Shammari, D. Hulcovรก, J. Maล™รญkovรก, T. Kuฤera, M. ล afratovรก, …
Journal: South African Journal of Botany, 136, 137-146
Year: 2021
Cited by: 26

Title: Alkaloid profiling of Hippeastrum cultivars by GC-MS, isolation of Amaryllidaceae alkaloids and evaluation of their cytotoxicity
Authors: L. Al Shammari, A. Al Mamun, D. Koutovรก, M. Majoroลกovรก, D. Hulcovรก, …
Journal: Records of Natural Products, 14 (2), 154-159
Year: 2020
Cited by: 26

Title: Phytochemical and biological studies of Carduus pycnocephalus L.
Authors: L.A. Al-Shammari, W.H.B. Hassan, H.M. Al-Youssef
Journal: Journal of Saudi Chemical Society, 19 (4), 410-416
Year: 2015
Cited by: 26

Title: Structure elucidation and cholinesterase inhibition activity of two new minor Amaryllidaceae alkaloids
Authors: J. Maล™รญkovรก, A.A. Mamun, L.A. Shammari, J. Korรกbeฤnรฝ, T. Kuฤera, D. Hulcovรก, …
Journal: Molecules, 26 (5), 1279
Year: 2021
Cited by: 23

Title: New pentacyclic triterpene ester and flavone glycoside from the biologically active extract of Carduus pycnocephalus L.
Authors: W.H.B. Hassan, H.M. Al-Youssef, A.L.S. Latifa, R.H. Abdallah
Journal: Journal of Pharmacognosy and Phytotherapy, 7 (4), 45-55
Year: 2015
Cited by: 9

Title: Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimerโ€™s disease: Synthesis, biological activity and in silico study
Authors: N. Maafi, F. Pidanรฝ, J. Maล™รญkovรก, J. Korรกbeฤnรฝ, D. Hulcovรก, T. Kuฤera, …
Journal: Bioorganic & Medicinal Chemistry Letters, 51, 128374
Year: 2021
Cited by: 6

Title: Amaryllidaceae alkaloids from Hippeastrum x hybridum cv. Ferrari, and preparation of vittatine derivatives as potential ligands for Alzheimerโ€™s disease
Authors: L.A. Shammari, D. Hulcovรก, J. Marikova, T. Kucera, M. Safratova, L. Novรกkovรก, …
Journal: South African Journal of Botany, 1-10
Year: 2020
Cited by: 5

Title: Alkaloids of genus Hippeastrum (Amaryllidaceae): isolation, identification, biological activity
Authors: L.A.M. Al Shammari
Journal: Univerzita Karlova, Farmaceutickรก fakulta v Hradci Krรกlovรฉ
Year: 2021
Cited by: 1

Conclusion

Dr. Latifah Al Shammari and collaborators demonstrates a sustained and impactful contribution to natural product chemistry, phytochemistry, and bioactive compound discovery. Spanning over a decade, these studies have advanced understanding of essential oils, alkaloids, and plant-derived metabolites with significant antimicrobial, cytotoxic, neuroprotective, and therapeutic potential. The research not only enriches botanical and pharmacological knowledge but also provides promising leads for drug discovery in areas such as Alzheimerโ€™s disease, cancer, and infectious diseases, highlighting the authorโ€™s role as a prominent and innovative contributor to pharmaceutical sciences.

Mohammed Dalli | Pharmacology of natural products | Best Paper Award

Posted on by The Scientist

Prof. Mohammed Dalli | Pharmacology of Natural Products | Best Paper Award

Assistant professor at Higher Institute of Nursing Professions and Health Techniques, Morocco.

Prof. Dr. Mohammed Dalli is an Assistant Professor at the Higher Institute of Nursing Professions and Health Techniques in Oujda, Morocco, and an associate member of the Laboratory of Bioresources, Biotechnology, and Health at Mohammed First University. Specializing in physiology and ethnopharmacology, his research centers on the isolation, characterization, and pharmacological evaluation of bioactive compounds from medicinal and aromatic plants. He has authored numerous publications in leading journals and holds seven patents related to plant-derived therapeutic compounds. Dr. Dalli also serves as an associate editor for the Journal of Cannabis Research (BMC Springer), supporting peer review integrity and scientific outreach. His interdisciplinary approach integrates traditional knowledge with modern pharmacological science to uncover new treatments for metabolic disorders and chronic diseases. Through a combination of innovative lab work, community health applications, and sustainable drug discovery, Dr. Dalli has emerged as a rising leader in natural product pharmacology.

Professional Profile

Scopus | ORCID | Google Scholar

Suitability For Best Paper Award – Prof. Mohammed Dalli

Prof. Dr. Mohammed Dalli is a highly suitable nominee for the Best Paper Award due to his innovative and impactful research in ethnopharmacology and natural product-based therapeutics. His work bridges traditional knowledge with modern pharmacological science, focusing on the isolation and evaluation of bioactive compounds from medicinal plants. His papers offer original scientific contributions, backed by robust methodology, novel compound discoveries, and relevance to global health challenges such as metabolic and infectious diseases. The quality, depth, and interdisciplinary scope of his research strongly align with the evaluation criteria of novelty, scientific rigor, practical impact, and scholarly excellence.

Education

Dr. Mohammed Dalli began his academic journey with a Bachelor’s degree in Life Sciences, specializing in Physiology and Health at Mohammed First University, Faculty of Sciences in Oujda, Morocco. He advanced to a Master’s program in Physiology and Health with a focus on Ethnopharmacology at the same institution, where he developed a deep interest in plant-based medicine and physiological interactions. Pursuing further specialization, he completed his Ph.D. in Physiology and Ethnopharmacology, where he conducted extensive research on bioactive compounds from traditional medicinal plants. His academic training provided a strong foundation in analytical chemistry, pharmacological testing, and physiological mechanisms, supported by advanced techniques like HPLC-UV, GC-MS, and in vitro bioassays. Each stage of his education deepened his interdisciplinary understanding of human health and traditional pharmacology, paving the way for a career focused on translating botanical knowledge into innovative therapeutic strategies for chronic and metabolic diseases.

Experience

Prof. Dr. Mohammed Dalli currently holds the position of Assistant Professor at the Higher Institute of Nursing Professions and Health Techniques in Oujda, under the Ministry of Health. In this academic role, he teaches courses related to physiology, pharmacology, and ethnopharmacology, and mentors students in research involving natural compounds and health science. Alongside his teaching duties, he is actively engaged as an associate member of the Laboratory of Bioresources, Biotechnology, and Health at Mohammed First University, where he leads research projects on medicinal plant extracts and their therapeutic applications. He has participated in several interdisciplinary collaborations involving antimicrobial resistance, metabolic disorders, and drug delivery systems. Prior to his professorship, Dr. Dalli contributed to various institutional research projects and worked closely with scientific teams on pharmacognosy and biocompatibility studies. His academic and research experience reflects a strong commitment to integrating traditional medicine with modern health science methodologies.

Professional Development

Dr. Dalli has pursued an impressive array of professional development activities, aimed at deepening his research and leadership capabilities. He has participated in specialized training programs in advanced analytical techniques such as HPLC-UV, GC-MS, and molecular docking, enhancing his proficiency in compound analysis and drug-target interaction studies. His involvement in national and international scientific workshops has broadened his understanding of pharmacognosy, plant biotechnology, and sustainable drug discovery. He has completed collaborative research exchanges with leading institutions where he further developed expertise in 3D drug delivery systems and in vitro pharmacological assays. As associate editor of a reputed international journal, he has taken part in peer-review training and editorial management seminars. Additionally, he has guided early-career researchers through manuscript writing, lab design, and experimental protocols. His professional growth is marked by both technical excellence and contributions to academic mentorship, making him a dynamic contributor to the global ethnopharmacology community.

Research Focus

Dr. Mohammed Dalli’s research focus lies in the fields of physiology, ethnopharmacology, and natural product-based therapeutic development. His core interest is in exploring medicinal and aromatic plants for bioactive compounds that can be applied to treat metabolic, microbial, and chronic health disorders. He combines in vitro biochemical testing with phytochemical profiling to identify therapeutic potentials of plant extracts. His studies often focus on key physiological processes, including glucose metabolism, antioxidant defense mechanisms, and enzyme inhibition relevant to diseases like diabetes and infections. Dr. Dalli is particularly interested in validating traditional herbal remedies through modern pharmacological science, aiming to bridge ancient knowledge systems with evidence-based health innovations. He also works on designing sustainable drug delivery systems using natural scaffolds. His multidisciplinary research contributes to fields such as pharmaceutical sciences, integrative medicine, and health biotechnology, positioning his work within global efforts toward safe, affordable, and eco-friendly healthcare solutions.

Research Skills

Dr. Mohammed Dalli possesses a versatile set of research skills that support his multidisciplinary investigations in physiology and ethnopharmacology. He is adept in chemical profiling using HPLC-UV and GC-MS to identify and quantify active constituents in plant extracts. His laboratory expertise extends to bioactivity screening techniques, including antioxidant assays, enzyme inhibition tests, antimicrobial evaluations, and glycation studies. He has a solid background in molecular docking and in silico modeling, allowing him to study drug-target interactions and optimize bioactive compound design. Dr. Dalli is experienced in preparing and testing 3D scaffolds for drug delivery, particularly using natural polymers and nanoformulations. He is proficient in statistical data analysis, research documentation, and scientific publishing. Moreover, he has experience in patent drafting and project management. His methodological precision and ability to integrate traditional botanical research with advanced health sciences have earned him recognition as a skilled and innovative researcher in plant-based pharmacology.

Awards and Honors

Dr. Mohammed Dalli has received multiple distinctions for his outstanding contributions to health sciences and pharmacology. He is the holder of seven patents related to plant-based extractions, compound isolation, and drug delivery technologies, reflecting his innovation in translating laboratory discoveries into practical applications. He has been recognized by his institution for excellence in research publications and knowledge dissemination. His work has garnered national attention for its relevance to public health and traditional medicine validation. He has been invited as a keynote speaker and award nominee at various scientific conferences focusing on natural products, medicinal plants, and drug development. In recognition of his scholarly impact, Dr. Dalli was appointed as associate editor of an international peer-reviewed journal in the field of cannabis and plant research. These accolades highlight his commitment to advancing natural medicine and promoting research excellence both nationally and internationally.

Publication Top Notes

Title: Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review
Journal: Biomolecules
Cited by: 96
Summary: This comprehensive review highlights the phytochemical profile and diverse pharmacological activities of Nigella sativa, such as antioxidant, antimicrobial, anti-inflammatory, and anticancer effects. It also addresses recent advancements and therapeutic potential based on studies.

Title: Evaluation of the In Vitro Antioxidant Activity of Different Extracts of Nigella sativa L. Seeds, and the Quantification of Their Bioactive Compounds
Journal: Materials Today: Proceedings
Cited by: 48
Summary: This experimental study evaluates antioxidant properties of various extracts from Nigella sativa seeds and quantifies major bioactive components such as phenolics and flavonoids.

Title: Molecular Composition and Antibacterial Effect of Five Essential Oils Extracted from Nigella sativa L. Seeds Against Multidrugโ€Resistant Bacteria
Journal: Evidence-Based Complementary and Alternative Medicine
Cited by: 43
Summary: This paper investigates the chemical composition and antibacterial effects of five essential oils from Nigella sativa seeds, especially against multidrug-resistant (MDR) bacteria.

Title: Assessment of the Antioxidant and Antimicrobial Potential of Ptychotis verticillata Duby Essential Oil from Eastern Morocco: An In Vitro and In Silico Analysis
Journal: Antibiotics
Cited by: 42
Summary: Combines laboratory (in vitro) and computational (in silico) approaches to evaluate the antioxidant and antimicrobial activities of Ptychotis verticillata essential oil.

Title: Multifunctional Smart Conducting Polymersโ€“Silver Nanocomposites-Modified Biocellulose Fibers for Innovative Food Packaging Applications
Journal: Industrial & Engineering Chemistry Research
Cited by: 33
Summary: Introduces smart nanocomposite materials combining conducting polymers and silver nanoparticles on biocellulose fibers for advanced food packaging with antimicrobial properties.

Title: Morocco: New Advances on Extraction, GC/MS Analysis, and Antioxidant Activity
Journal: Natural Product Research
Cited by: 31
Summary: Discusses improved extraction methods, chemical profiling using GC/MS, and antioxidant evaluation of Rosmarinus officinalis (rosemary) essential oils from Morocco.

Title: Chemical Composition Analysis Using HPLC-UV/GC-MS and Inhibitory Activity of Different Nigella sativa Fractions on Pancreatic ฮฑ-Amylase and Intestinal Glucose Absorption
Journal: Not specified
Cited by: 30
Summary: Explores the anti-diabetic potential of various Nigella sativa seed fractions by studying enzyme inhibition (ฮฑ-amylase) and effects on glucose absorption.

Conclusion

Prof. Dr. Mohammed Dalliโ€™s scholarly record and interdisciplinary research contributions make him an outstanding candidate for the Best Paper Award. His ability to integrate traditional ethnopharmacological wisdom with state-of-the-art biomedical science results in high-quality, impactful publications. The scientific originality, real-world relevance, and innovation-driven outcomes reflected in his work not only merit recognition but also exemplify the essence of what the Best Paper Award stands for.

Jong-Sup Bae | Pharmaceutical Sciences | Best Paper Award

Posted on by The Scientist

Prof. Dr. Jong-Sup Bae | Pharmaceutical Sciences | Best Paper Award

Professor at Kyungpook National University, South Korea.

Dr. Jong-Sup Bae is a distinguished professor of pharmaceutical sciences at Kyungpook National University, Republic of Korea, with a global reputation in drug development, molecular pharmacology, and translational research. He has published over 350 SCI-indexed papers, including high-impact journals such as Blood, PNAS, Advanced Materials, and Science Advances, with over 12,749 citations and an h-index of 57. His leadership roles include Director of the Research Institute of Pharmaceutical Sciences and Dean of the College of Pharmacy. His extensive work in developing therapeutic agents and biomaterials is backed by 71 patents (15 international and 56 domestic). He has been honored with prestigious awards, including the Minister of Health and Welfare Award and multiple Most Cited Paper Awards. His pioneering contributions continue to shape the landscape of pharmaceutical sciences in Korea and globally.

Professional Profile

Scopus

Suitability For Best Paper Award – Prof. Dr. Jong-Sup Bae

Dr. Jong-Sup Bae, a renowned professor at Kyungpook National University, is exceptionally well-qualified for the Best Paper Award. His candidacy is supported by a stellar academic track record comprising over 350 SCI-indexed publications, 12,749 citations, and a high h-index of 57โ€”clear indicators of sustained scholarly impact. His key contributions include cutting-edge research in molecular pharmacology, nanomedicine, and inflammatory disease mechanisms, all published in top-tier journals like Science Advances, Advanced Materials, Blood, and PNAS. A standout contribution is his recent work on 3-Deoxysappanchalcone, which demonstrates novel anti-thrombotic mechanisms with potential therapeutic applicationโ€”precisely the kind of innovation this award seeks to honor.

Dr. Jong-Sup Bae’s strength lies in his ability to translate molecular discoveries into therapeutic candidates, leveraging advanced drug delivery systems and bioinformatics. His work consistently bridges basic science and translational outcomes. Notably, he holds 71 patents, highlighting the originality and applied value of his research.

Additionally, his role as Director of the Research Institute of Pharmaceutical Sciences and Dean of the College of Pharmacy amplifies his influence on research strategy and mentoring. Multiple recognitionsโ€”including the Minister of Health and Welfare Award, Science and Technology Excellent Paper Award, and Most Cited Paper Awardsโ€”attest to his national and international research excellence.

Education

Dr. Jong-Sup Bae received rigorous training in pharmaceutical sciences and biomedical research through an integrated academic path that laid the foundation for his translational and interdisciplinary research. He earned his bachelorโ€™s and masterโ€™s degrees in pharmaceutical sciences, followed by a Ph.D. in pharmacology or a related field (exact details not provided in your data; please confirm). During his academic journey, he specialized in molecular pharmacology, drug development, and bioactive compounds, receiving advanced training in both laboratory and clinical-oriented research methodologies. His doctoral work was instrumental in developing a strong foundation in pharmacokinetics, cellular signaling pathways, and therapeutic design. This educational background has enabled him to pursue impactful research at the interface of molecular medicine and pharmacotherapy, influencing future drug candidates and treatment modalities. His academic excellence has been reflected in both teaching and research capacities, forming a strong base for his career in academia and pharmaceutical innovation.

Experience

Dr. Jong-Sup Bae has accumulated over 17 years of academic and research experience in pharmaceutical sciences. He served as Assistant Professor in the Department of Pharmaceutical Engineering at Daegu Haany University. He has held progressive academic positionsโ€”Assistant Professor, Associate Professor, and currently Full Professorโ€”at the College of Pharmacy, Kyungpook National University. His appointment as Director of the Research Institute of Pharmaceutical Sciences and as Dean of the College reflects his strategic leadership in advancing Korea’s pharmaceutical research ecosystem. His laboratory focuses on molecular mechanisms of disease and the development of innovative drug delivery systems. Under his mentorship, numerous graduate students and postdoctoral researchers have made notable scientific contributions. He also plays an editorial role in leading journals and contributes to national research initiatives and government-led scientific projects, positioning himself as a prominent figure in pharmaceutical and biomedical research.

Professional Development

Dr. Jong-Sup Bae has consistently advanced his professional standing through research leadership, scholarly output, and academic administration. His career trajectory reflects excellence in teaching, mentorship, publication, and innovation. As Dean and Director, he has championed interdisciplinary collaboration and promoted translational research. His international patents and high-impact publications demonstrate an ability to move from fundamental discovery to clinical application. He actively participates in scientific conferences, editorial boards, and academic societies, strengthening both his knowledge and professional network. Notably, his roles as Editor for Biotechnology and Bioprocess Engineering and advisor to scientific bodies position him at the forefront of pharmaceutical innovation. His proactive involvement in governmental and institutional research programs underscores his commitment to public health and policy-oriented science. Through these initiatives, he not only fosters institutional growth but also contributes to the global scientific community by mentoring emerging scholars and advancing pharmaceutical sciences in South Korea and beyond.

Research Focus

Dr. Jong-Sup Bae specializes in translational pharmaceutical research with a particular focus on molecular pharmacology, drug discovery, nanomedicine, and inflammatory disease mechanisms. His research aims to elucidate cellular signaling pathways related to inflammation, thrombosis, and metabolic disorders to develop effective therapeutic candidates. He has pioneered work on drug delivery systems, including nanoparticle-based formulations and targeted delivery for anti-inflammatory and anti-thrombotic agents. His investigations often bridge basic molecular insights with clinical relevance, evidenced by the development of compounds like 3-Deoxysappanchalcone for anti-thrombotic activity. His teamโ€™s work has led to innovative therapies published in top-tier journals such as Science Advances, Biomaterials, and Advanced Functional Materials. Dr. Jong-Sup Bae’s research focus also includes immune modulation, respiratory diseases, and renal pharmacology, reflecting a broad yet integrated scientific agenda. Through strategic collaborations, he continues to advance the development of next-generation pharmaceuticals with both academic and industrial impact.

Research Skills

Dr. Jong-Sup Bae possesses an extensive range of research skills centered around molecular biology, pharmacokinetics, bioinformatics, drug screening, and nanotechnology-based drug delivery systems. He is adept in cell culture techniques, gene/protein expression analysis (e.g., Western blotting, qPCR), and molecular docking. His group employs in vivo and in vitro models to study disease mechanisms and drug efficacy, especially in inflammation, thrombosis, and metabolic diseases. He has strong expertise in formulating novel drug delivery carriers such as nanoparticles and hydrogels to enhance bioavailability and targeting precision. Furthermore, he integrates systems biology and omics approaches to identify therapeutic targets. With a solid grasp of patent writing and regulatory aspects, he has translated his research into over 70 patents. His skills also extend to mentoring, grant writing, and international collaboration, making him a versatile and strategic researcher who consistently delivers high-impact scientific outcomes.

Awards and Honors

Dr. Jong-Sup Bae has been recognized with over 15 prestigious awards celebrating his scientific excellence and innovation. Among these are multiple โ€œMost Cited Paper Awardsโ€ and โ€œAcademic Journal Achievement Awardsโ€ from BMB Reports, highlighting his consistent scholarly impact. He was honored with the โ€œYoung Pharmacist Awardโ€ by The Pharmaceutical Society of Korea and the โ€œMinister of Health and Welfare Award,โ€ reflecting both academic and societal contributions. His work has also earned the โ€œTop 5 Domestic Bio Research Achievementsโ€ by BRIC and the โ€œScience and Technology Excellent Paper Awardโ€ by the Korean Federation of Science and Technology Societies. As the recipient of the Blue Ribbon Lectureship and the Beomseok Thesis Award, his early career promise has matured into sustained excellence. His accolades reflect peer recognition at the national and international levels, solidifying his reputation as a leader in pharmaceutical sciences.

Publication Top Notes

Title:ย Anti-Thrombotic Activity of 3-Deoxysappanchalcone via Inhibiting Platelet Aggregation and Thrombin (FIIa)/Activated Factor X (FXa) Activity
Journal: Molecules
Summary:
This study shows that 3-deoxysappanchalcone (3-DSC) significantly inhibits platelet aggregation and coagulation by targeting thrombin (FIIa) and factor Xa (FXa). The dual inhibition highlights its potential as a promising anti-thrombotic compound.

Title:ย 3-Deoxysappanchalcone Inhibited High Mobility Group Box Protein 1-Mediated Severe Inflammatory Responses
Journal: Pharmaceuticals
Citation Count:ย 1
Summary:
3-DSC suppressed HMGB1-induced inflammation by downregulating pro-inflammatory cytokines and blocking NF-ฮบB activation. This suggests its potential role in managing HMGB1-related inflammatory disorders.

Title:ย Guillain-Barrรฉ Syndrome during the COVID-19 Era: A Nationwide Study of Hospitalized Cases in South Korea
Journal: Medicine (United States)
Summary:
A large-scale analysis of GBS cases in South Korea during the COVID-19 pandemic revealed changing incidence and clinical features, possibly associated with SARS-CoV-2 infection. The study offers epidemiological insights into virus-related neurological disorders.

Title:ย The Beneficial Effects of CGK012 Against Lipopolysaccharide-Induced Inflammation
Journal: Journal of Medicinal Food
Summary:
CGK012 was shown to suppress LPS-induced inflammation by inhibiting TNF-ฮฑ and IL-6 production and blocking NF-ฮบB signaling. These anti-inflammatory properties suggest therapeutic promise in inflammatory diseases.

Title:ย The Guanine Nucleotide Exchange Factor DOCK5 Negatively Regulates Osteoblast Differentiation and BMP2-Induced Bone Regeneration via the MKK3/6 and p38 Signaling Pathways
Journal:ย Experimental and Molecular Medicine
Citation Count:ย 2
Summary:
DOCK5 impairs osteoblast differentiation and bone regeneration by suppressing BMP2-mediated activation of the MKK3/6-p38 MAPK pathway. Inhibition of DOCK5 may enhance bone healing.

Title:ย Inhibitory Effects of Decursin Derivative Against Lipopolysaccharide-Induced Inflammation
Journal:ย Pharmaceuticals
Citation Count:ย 2
Summary:
The decursin derivative significantly reduced inflammatory markers in an LPS-induced model by targeting MAPK and NF-ฮบB pathways, confirming its potential as an anti-inflammatory compound.

Title:ย Glycinamide Facilitates Nanocomplex Formation and Functions Synergistically with Bone Morphogenetic Protein 2 to Promote Osteoblast Differentiation In Vitro and Bone Regeneration in a Mouse Calvarial Defect Model
Journal:ย Tissue Engineering and Regenerative Medicine
Citation Count:ย 1
Summary:
Glycinamide synergizes with BMP2 to enhance osteoblast differentiation and bone healing in a skull defect model. It also aids in nanocomplex formation, improving therapeutic delivery.

Title:ย Suppressive Activities of Lupeol on Sepsis Mouse Model
Journal: Biotechnology and Bioprocess Engineering
Citation Count:ย 1
Summary:
Lupeol reduced mortality and systemic inflammation in a sepsis model by lowering pro-inflammatory cytokine levels. The compound shows promise as a protective agent in sepsis therapy.

Title:ย The Beneficial Effects of Lupeol on Particulate Matterโ€“Mediated Pulmonary Inflammation
Journal: Food and Chemical Toxicology
Citation Count:ย 2
Summary:
Lupeol mitigated lung inflammation caused by airborne particulate matter. It reduced oxidative stress and inflammatory cytokines, indicating its potential in respiratory protection.

Title:ย Napyradiomycin B4 Suppresses RANKL-Induced Osteoclastogenesis and Prevents Alveolar Bone Destruction in Experimental Periodontitis
Journal:ย ACS Pharmacology and Translational Science
Citation Count:ย 3
Summary:
Napyradiomycin B4 inhibits RANKL-induced osteoclast formation and prevents bone loss in periodontitis models. It offers therapeutic value in treating bone-destructive conditions.

Conclusion:

Dr. Jong-Sup Bae is not only a prolific and high-impact researcher but also a translational innovator whose contributions have advanced pharmaceutical sciences significantly. His recent high-caliber publications, especially in disease-modifying drug development, strongly qualify him for the Best Paper Award. His achievements embody the awardโ€™s goals: to recognize originality, scientific rigor, and real-world impact in pharmaceutical research. Therefore, he is an outstanding and deserving candidate for the Best Paper Award.

Ange Cynthia Umuhire | Solar Physics | Young Scientist Award

Posted on by The Scientist

Dr. Ange Cynthia Umuhire | Solar Physics | Young Scientist Award

Lecturer at University of Rwanda, Rwanda.

Dr. Ange Cynthia Umuhire is a Rwandan astrophysicist and lecturer at the University of Rwanda โ€“ College of Science and Technology. An early-career scientist with a Ph.D. in Astronomy and Space Sciences, she specializes in heliophysics, solar radio bursts, and space weather research. Dr. Umuhire has collaborated with leading institutions including NASA, the World Bank, and the African Astronomical Society. She is recognized for her outstanding academic contributions and mentorship efforts, particularly in promoting women in STEM fields. Through her involvement in space research, academic teaching, and youth outreach, she is driving forward the scientific capacity of Africa in space sciences. With several prestigious awards and international fellowships, Dr. Umuhireโ€™s commitment to both fundamental research and societal engagement highlights her as a rising leader in the African scientific community. Her multidisciplinary expertise and advocacy reflect a strong vision for inclusive, innovation-driven space science development across the continent.

Professional Profile:

Scopus Profile | ORCID Profile

Suitability For Young Scientist Award – Dr. Ange Cynthia Umuhire

Dr. Ange Cynthia Umuhire exemplifies the qualities expected of a Young Scientist Award recipient: she is an early-career researcher with a Ph.D. in Astronomy and Space Sciences, a robust record of scientific publications, international collaborations (e.g., NASA, ICTP, World Bank), and an expanding portfolio of leadership in research, education, and outreach. Her work in heliophysics and space weather, focusing on solar radio bursts and their Earth-bound impacts, contributes significantly to a growing yet underrepresented field in Africa. Her interdisciplinary and globally collaborative research, combined with her outreach to empower young African women in STEM, underscores her holistic impact.

Education

Dr. Umuhireโ€™s academic journey reflects her deep commitment to space science and astrophysics. She earned her Ph.D. in Astronomy and Space Sciences from the University of Rwanda (2019โ€“2023), focusing on solar-terrestrial interactions and space weather phenomena. Prior to this, she completed a Master of Science in Space Physics from Mbarara University of Science and Technology in Uganda (2016โ€“2018), where she laid the foundation for her expertise in solar emissions and geospace dynamics. Her undergraduate education culminated in a Bachelor of Science with Honors in Applied Physics (Material Science) from the University of Rwanda (2012โ€“2016). Throughout her academic path, Dr. Umuhire consistently demonstrated excellence, receiving support for international research internships and fellowships. Her formal education has been further enriched by non-degree research programs across Spain, Kenya, and Ethiopia, contributing to her well-rounded understanding of space science in both African and global contexts.

Experience

Dr. Umuhireโ€™s professional experience spans academia, research institutions, and international development organizations. She currently serves as a lecturer at the University of Rwanda โ€“ College of Science and Technology, where she teaches space science and supervises undergraduate research. From 2019 to 2023, she held a research position at the same institution, contributing to solar-terrestrial physics studies. Her international experience includes serving as a space science consultant with the World Bank (2024) and as a STEM coordinator at George Mason University. She has worked with the African Astronomical Society and the Rwanda Space Agency, applying satellite and GNSS data analysis to monitor solar events and their terrestrial impacts. Notably, she interned at NASA-Goddard Space Flight Center in 2019 and conducted long-term collaborative research with ICTP across multiple African and European sites. Her multidisciplinary roles showcase a blend of teaching, policy engagement, and technical research in astrophysics and space development.

Professional Development

Dr. Umuhire has actively pursued diverse professional development opportunities to strengthen her scientific and leadership capacities. She participated in long-term research internships through the International Centre for Theoretical Physics (ICTP), where she enhanced her practical skills in radio astronomy, data modeling, and geospace forecasting across countries like Spain, Kenya, and Ethiopia. She was selected for international leadership events such as the World Space Forum and the Iberian Space Summer School. In her role as STEM coordinator for George Mason University (remote), she facilitated capacity-building initiatives for African students and professionals. She has also engaged in curriculum design and policy advisory roles, contributing to institutional development in Rwandaโ€™s higher education system. Her participation in grant-writing mentorship and academic panels reflects her dedication to empowering the next generation of scientists. Through fellowships like the MAWAZO Learning Exchange and international awards, Dr. Umuhire has developed not only scientific acumen but also strong outreach, ethics, and advocacy competencies.

Research Focus

Dr. Umuhireโ€™s research falls under the category of heliophysics and space weather, with a particular emphasis on solar-terrestrial interactions. Her studies focus on the behavior of solar radio bursts, coronal mass ejections (CMEs), and their influence on Earthโ€™s magnetosphere, ionosphere, and technological systems. She investigates GNSS signal disruptions and space weather forecasting models, making her research highly relevant to both scientific inquiry and real-world applications in communication, navigation, and climate systems. She is also interested in the health and environmental implications of solar activity. This focus area is critical to space science and atmospheric studies, especially as space weather increasingly affects satellite infrastructure, aviation, and global positioning systems. Dr. Umuhireโ€™s work not only contributes to fundamental astrophysics but also addresses regional knowledge gaps, especially in Africa, by enhancing predictive capabilities and space science literacy through her dual focus on research and public engagement.

Research Skills

Dr. Umuhire possesses a broad and technically advanced set of research skills, particularly within data-intensive astrophysics and space weather modeling. She is proficient in scientific programming languages such as Python, MATLAB, IDL, and R, which she uses for analyzing solar emissions, GNSS disruptions, and satellite-based datasets. Her familiarity with key astronomy softwareโ€”such as TOPCAT, DS9, GALFIT, and STARLIGHTโ€”supports her expertise in image analysis and solar activity simulation. In addition to scientific computing, she has strong command of LaTeX and GIS tools, vital for documentation and geographic visualization of solar-terrestrial phenomena. Her skills also include satellite telemetry, ionospheric modeling, and coronal imaging analysis. These competencies are complemented by her experience in designing data-driven models to predict solar impacts on Earthโ€™s technological systems. Her ability to bridge observational astronomy, computational modeling, and applied geospace physics makes her skillset both versatile and highly relevant for modern heliophysical research.

Awards and Honors

Dr. Ange Cynthia Umuhire has received multiple prestigious awards in recognition of her scientific contributions and advocacy in STEM. In 2023, she was honored with the Grace Hopper Abie Award โ€“ Student of Vision in the United States, highlighting her forward-thinking leadership and impact as a young scientist. In 2022, she received the Lโ€™Orรฉal-UNESCO For Women in Science Sub-Saharan Africa Young Talents Award, a highly competitive accolade celebrating her research excellence and efforts to promote women in science across Africa. That same year, she was selected as a MAWAZO Learning Exchange Fellow, further recognizing her role in capacity building and academic mentorship. These accolades reflect her dedication not only to cutting-edge heliophysics research but also to broader social transformation through science. Her award record demonstrates international validation of her academic promise, technical expertise, and leadership in promoting diversity, education, and scientific development in Africa and beyond.

Publication Top Notes

An assessment of potentially space weather causing CMEs through analysis of associated interplanetary type II solar radio bursts and solar energetic particle events

Journal of Atmospheric and Solar-Terrestrial Physics
Publication Date: September 2025
Contributors: A.C. Umuhire, N. Gopalswamy, J. Uwamahoro
Summary: This study examines the space weather potential of coronal mass ejections (CMEs) by analyzing their association with interplanetary Type II radio bursts and solar energetic particle (SEP) events. The analysis helps in identifying CME characteristics linked with significant geoeffective outcomes, contributing to forecasting models.

Simultaneous evaluation of solar activity proxies during geomagnetic storms using principal component analysis: Case study of the African low and mid-latitude regions

Journal of Atmospheric and Solar-Terrestrial Physics
Publication Date: May 2025
Contributors: Jean Claude Uwamahoro, John Bosco Habarulema, Dalia Buresova, Nigussie Mezgebe Giday, Valence Habyarimana, Kateryna Aksonova, Joseph Ntahompagaze, Theogene Ndacyayisenga, Ange Cynthia Umuhire
Summary: This paper applies principal component analysis (PCA) to evaluate solar activity proxies during geomagnetic storms across low- and mid-latitude African regions. It reveals regional responses and the complex interplay between solar and geomagnetic activity, contributing to localized space weather modeling.

Properties of High-Frequency Type II Radio Bursts and Their Relation to the Associated Coronal Mass Ejections

Solar Physics
Publication Date: January 2021
Contributors: A.C. Umuhire, N. Gopalswamy, J. Uwamahoro, S. Akiyama, S. Yashiro, P. Mรคkelรค
Summary: This article investigates high-frequency Type II radio bursts, their properties, and how they correlate with the characteristics of the associated CMEs. It enhances understanding of CME-driven shock generation and radio burst emissions, supporting better interpretation of solar radio data for space weather predictions.

Conclusion

Dr. Ange Cynthia Umuhire meets and exceeds the standard criteria for the Young Scientist Award. Her innovative research, international impact, and transformative educational leadership position her as a role model for the next generation of African scientists. Her trajectory showcases not only scientific excellence but also an enduring commitment to inclusivity, mentorship, and applied knowledge for societal benefit.

Kaan Koรงali | Occupational Health and Safety | Best Researcher Award

Posted on by The Scientist

Assist. Prof. Dr. Kaan Koรงali | Occupational Health and Safety | Best Researcher Award

Occupational Health and Safety at Istanbul Gelisim University, Turkey.

Asst. Prof. Kaan Koรงali is a Turkish academic and researcher specializing in occupational health and safety, with a robust interdisciplinary background in mining engineering and workplace risk assessment. Currently serving at Istanbul GeliลŸim Universityโ€™s Vocational School, he is also Head of the Department of Occupational Health and Safety and holds key roles in curriculum development, quality assurance, and Erasmus coordination. Dr. Koรงaliโ€™s academic journey is underpinned by a strong foundation in engineering and entrepreneurship, complemented by his doctoral research on legal responsibilities in mining supervision. He is an active contributor to national and international academic literature, with a publication record spanning peer-reviewed journals, books, and technical articles. Dr. Koรงali also brings extensive practical expertise through professional certifications in ISO standards, NEBOSH, and fire safety, reflecting his commitment to bridging theory with real-world applications in occupational safety. His work is widely cited, particularly in mining safety, risk assessment, and workplace health analytics.

Professional Profile

Scopus Profile | Google Scholar | ORCID Profile

Suitability for Best Researcher Award – Assist. Prof. Dr. Kaan Koรงali

1. Interdisciplinary Expertise:
Dr. Koรงali bridges engineering, occupational safety, and legal compliance, an integration that is essential for addressing modern workplace hazards in high-risk industries like mining, construction, and transportation.

2. Proven Research Impact:
He has published widely in peer-reviewed and indexed journals, including contributions to accident standardization, safety analytics, and supervisor legal responsibilitiesโ€”a niche yet crucial area for national and industrial policy development.

3. Applied and Policy-Relevant Work:
His research supports real-world application, including digital safety monitoring tools, accident analysis frameworks, and standardization of occupational indicators, showing direct societal and regulatory relevance.

4. Capacity Building & Academic Leadership:
As Head of Department, Erasmus Coordinator, and Ethics Committee Member, Dr. Koรงali shows leadership that extends beyond research, contributing to institutional development and internationalization.

5. Continuous Professional Development:
Over 30+ certifications, including NEBOSH, ISO Lead Auditor, and fire safety instructor training, highlight his lifelong learning mindset and commitment to academic-practical integration.

6. National Contribution & Recognition:
While formal international awards may be limited, he has received institutional honors, professional certifications, and holds key strategic academic roles. His influence on Turkeyโ€™s occupational safety landscapeโ€”through research and regulatory alignmentโ€”underscores his national impact.

Education

Dr. Kaan Koรงali holds a diverse and comprehensive academic background. He earned his Ph.D. in Occupational Health and Safety from Istanbul Aydin University (2017โ€“2021), where his dissertation focused on legal obligations and digital monitoring systems for permanent mining supervisors. He also completed two postgraduate degrees: one from Istanbul Aydin University in Occupational Health and Safety (2015โ€“2016) and another from ฤฐstanbul University-CerrahpaลŸa in Mining Engineering (2011โ€“2016). His undergraduate journey began with a B.Sc. in Mining Engineering (2007โ€“2011) at ฤฐstanbul University-CerrahpaลŸa, followed by a second undergraduate degree in Business Administration from Anadolu University (2010โ€“2021). Most recently, he has been pursuing studies in Entrepreneurship at Istanbul Kultur University since 2021. This multidisciplinary academic foundation equips Dr. Koรงali with a unique blend of technical, managerial, and entrepreneurial perspectives, aligning strongly with his research and professional pursuits in occupational safety, mining risk management, and regulatory compliance.

Experience

Dr. Koรงali has cultivated a distinguished academic and administrative career at Istanbul GeliลŸim University since 2021. As Assistant Professor and Head of the Department of Occupational Health and Safety, he is actively involved in teaching, research, and leadership roles, including chairing the Performance Evaluation Commission and coordinating Erasmus programs. His administrative involvement includes serving on the Ethics Committee, Internship and Curriculum Boards, Vocational School Council, and Alumni Relations Commission. Dr. Koรงali also contributes to horizontal transfer and cafeteria supervision committees, reflecting his institutional versatility. Academically, he delivers a broad array of undergraduate and postgraduate courses on risk management, fire safety, biological hazards, and integrated management systems. Prior to academia, his experience in the mining industry and project management provided critical real-world insight that he now applies in educational settings. His professional background reinforces his commitment to enhancing occupational safety culture through education, policy development, and interdisciplinary collaboration.

Professional Development

Dr. Koรงali has completed over 30 certifications and training programs spanning occupational health and safety, quality management, project design, and technical mining competencies. He holds A, B, and C-Class Occupational Health and Safety Expert certificates and has completed NEBOSHโ€™s International General Certificate, Process Safety, and Safety Leadership programs. His ISO certifications include ISO 9001, ISO 14001, ISO 45001, and ISO 22000 internal auditing and documentation. Dr. Koรงali also completed courses on fire risk management, workplace inspections, and emergency preparedness, such as Afet Farkฤฑndalฤฑk and Yangฤฑn EฤŸitmenliฤŸi. He has further enhanced his qualifications with courses in project writing, drone piloting, teaching methodology, and mental tool mastery through McMaster University. His continuous professional development demonstrates a strong commitment to lifelong learning and aligns with his goals of integrating applied safety solutions and regulatory compliance into academic and industrial settings, especially in high-risk sectors such as mining, construction, and manufacturing.

Research Focus

Dr. Koรงaliโ€™s research lies at the intersection of occupational health and safety, ergonomics, and social policy, with a specific emphasis on high-risk industries such as mining and transportation. His studies address critical safety concerns, including work accident analysis, occupational diseases, safety culture, risk management, and legal responsibilities of supervisors. His scholarly contributions explore accident statistics, ergonomic assessment, anthropometric evaluations, and international labor regulations, often employing tools like the Fine-Kinney and TOPSIS methods for risk and safety evaluations. He is particularly engaged in standardization of work accident indicators, development of safety performance metrics, and regional safety planning. Through an interdisciplinary lens, he connects engineering principles, legal frameworks, and managerial strategies to design safer workplaces. His work not only serves the academic community but also informs public policy, labor standards, and industrial practices, particularly within the context of Turkeyโ€™s evolving occupational safety infrastructure.

Research Skills

Dr. Koรงali possesses a rich skill set in risk assessment modeling, safety performance analysis, and qualitative and quantitative data interpretation relevant to occupational health sciences. He is proficient in applying structured methodologies like Fine-Kinney, TOPSIS, and anthropometric analysis to assess workplace hazards and evaluate safety protocols. His technical mining background further enhances his capacity to analyze complex systems such as underground blasting operations and accident causality in high-risk environments. He has demonstrated expertise in developing digital tools for compliance monitoring and legal tracking in workplace safety, as evident from his doctoral dissertation. Dr. Koรงali also integrates ISO-based management systems (9001, 14001, 45001, 22000) into risk-based safety design. His competencies include scholarly writing, field surveys, policy evaluation, and curriculum development, contributing to national and international discourse in occupational safety. These skills position him as a valuable researcher and educator in the fields of ergonomics, work design, and regulatory health systems.

Awards and Honors

While no specific competitive awards are listed, Dr. Kaan Koรงaliโ€™s honors are embedded in his academic appointments, certifications, and professional recognition. Being appointed as Head of Department and Performance Evaluation Commission Chair at Istanbul GeliลŸim University reflects institutional acknowledgment of his leadership and subject expertise. His certifications from globally respected institutions such as NEBOSH, IOSH, and SIGMACERT Globalโ€”including lead auditor and safety specialist credentialsโ€”demonstrate high-level professional recognition. Additionally, he is entrusted with quality assurance, Erasmus coordination, and educational strategy, which signifies peer recognition of his multidisciplinary impact and administrative reliability. His scholarly outputโ€”comprising multiple peer-reviewed journal articles, including those indexed in SSCI and Scopusโ€”is a testament to his research quality and relevance. Furthermore, his involvement in the Turkish occupational safety regulatory framework, including work on post-disaster analysis, labor inspections, and risk standardization, positions him as a thought leader in the domain of occupational health and safety in Turkey.

Publication Top Notes

Sosyal Gรผvenlik Kurumuโ€™nun 2012โ€“2020 Yฤฑllarฤฑ Arasฤฑ ฤฐลŸ Kazalarฤฑ Gรถstergelerinin Standardizasyonu
Akademik YaklaลŸฤฑmlar Dergisi, Vol. 12(2), pp. 302โ€“327
Cited by: 46 | Year: 2021
Summary: Proposes a standardized framework for evaluating occupational accident indicators from the Turkish Social Security Institution (SGK) between 2012โ€“2020, improving data consistency and comparison in labor safety research.

Calculation of Occupational Accident Indicators of Tรผrkiye
INSAC Social and Education Sciences, pp. 222โ€“250
Cited by: 18 | Year: 2021
Summary: Presents a methodology for calculating national-level occupational accident rates in Tรผrkiye, aiding policymakers and safety professionals in evidence-based decision-making.

Maden Kazalarฤฑnda Sorumluluklar ve Kusur Oranlarฤฑ
Nobel Yayฤฑn Kitapevi
Cited by: 14 | Year: 2021
Summary: Analyzes legal responsibilities and fault ratios in mining accidents, offering insights into liability allocation between employees, employers, and contractors.

Aรงฤฑk Ocak Maden ฤฐลŸletmelerinde ฤฐลŸรงi Anketleri ile ฤฐลŸ SaฤŸlฤฑฤŸฤฑ ve GรผvenliฤŸi Kรผltรผrรผ ve Uygulamasฤฑnฤฑn AraลŸtฤฑrฤฑlmasฤฑ
Bilimsel Madencilik Dergisi, Vol. 57(1), pp. 15โ€“24
Cited by: 14 | Year: 2018
Summary: Investigates occupational health and safety (OHS) culture in open-pit mining through worker surveys, highlighting gaps in practice versus policy.

ลžฤฑrnak Kรถmรผr Madeni Kazasฤฑ IลŸฤฑฤŸฤฑnda Kรถmรผr MadenciliฤŸindeki Uygunsuzluklar Hakkฤฑnda ร–neriler
ICCET 2018 Bildiriler Kitabฤฑ, pp. 387โ€“399
Cited by: 10 | Year: 2018
Summary: Uses the ลžฤฑrnak coal mine disaster as a case study to suggest actionable recommendations for addressing safety noncompliance in Turkish coal mining.

How to Perform a Risk Assessment Step by Step for Occupational Health and Safety
EURAS Journal of Engineering and Applied Sciences, Vol. 2(1), pp. 1โ€“19
Cited by: 7 | Year: 2022
Summary: Offers a practical, structured approach to conducting workplace risk assessments aligned with occupational health and safety standards.

Legal Regulations Regarding Liabilities of Workers and Employers Related to Occupational Health and Safety in Mining
Ulusal BaลŸkent Disiplinler Arasฤฑ Bilimsel ร‡alฤฑลŸmalar Kongresi, pp. 357โ€“358
Cited by: 7 | Year: 2021
Summary: Reviews Turkish legal statutes governing the OHS responsibilities of employers and employees in the mining sector.

Madencilikte Proje ลžirketlerinin ร–nemi
Maden Ocak Teknolojileri Dergisi, pp. 82โ€“86
Cited by: 6 | Year: 2013
Summary: Discusses the strategic role of project-based companies in mining operations and their influence on operational safety and efficiency.

18โ€“65 YaลŸ Arasฤฑ KiลŸilerin Antropometrik Verilerinin Belirlenmesi รœzerine Bir Alan AraลŸtฤฑrmasฤฑ: YรผksekรถฤŸretim Kurumu Uygulamasฤฑ
Ergonomi, Vol. 4(3), pp. 147โ€“161
Cited by: 5 | Year: 2021
Summary: Conducts a field study on anthropometric measurements of adults aged 18โ€“65 to inform ergonomic design in higher education institutions.

Tรผrkiyeโ€™de 2017 Yฤฑlฤฑnda YaลŸanan Kรถmรผr Madeni Faciasฤฑ Sonrasฤฑ Sektรถrรผn ฤฐลŸ SaฤŸlฤฑฤŸฤฑ ve GรผvenliฤŸi Aรงฤฑsฤฑndan ฤฐrdelenmesi
The Journal of Academic Social Science, Vol. 95, pp. 486โ€“496
Cited by: 5 | Year: 2019
Summary: Examines the OHS implications of the 2017 coal mining disaster in Tรผrkiye and evaluates subsequent sectoral reforms and shortcomings.

Conclusion

Dr. Kaan Koรงali is an exemplary mid-career academic-researcher who has made distinctive, policy-informing, and socially impactful contributions to the field of occupational health and safety. His blend of research productivity, professional certifications, educational leadership, and real-world application makes him highly suitable for the Best Researcher Awardโ€”particularly in categories honoring applied sciences, public safety, or interdisciplinary engineering.

Milo Frattini | Molecular Biology | Best Researcher Award

Posted on by The Scientist

Dr. Milo Frattini | Molecular Biology | Best Researcher Award

Head of Biologists, quality and research of ICP at ICP EOC, Switzerland.

Dr. Milo Frattini is a distinguished molecular pathologist with over two decades of experience in translational cancer research. He currently serves as the Head of the Laboratory of Molecular Pathology at the Institute of Pathology, Ente Ospedaliero Cantonale, in Locarno, Switzerland. An Italian national, Dr. Frattini completed his early studies in Milan and went on to obtain a Ph.D. in Experimental Medicine and Oncology from the University of Insubria. His scientific journey reflects a strong commitment to oncology, molecular diagnostics, and quality assurance in clinical pathology. Dr. Frattini has authored over 100 peer-reviewed publications and several book chapters, and he plays a prominent role in editorial boards, including BMC Cancer and the Journal of Clinical Medicine. He is also a member of key professional societies such as the Swiss Society of Pathology and SAKK groups for gastrointestinal and lung cancer. His research significantly contributes to precision medicine and cancer care.

Professional Profile

Scopus

Orcid

Sutability For Best Researcher Award – Dr. Milo Frattini

Dr. Milo Frattini is an exceptionally strong candidate for the Best Researcher Award based on his extensive contributions to molecular oncology, translational cancer research, and diagnostic innovation. With over 20 years of impactful research, he has established himself as a scientific leader in integrating molecular diagnostics into routine cancer care. His sustained publication record (100+ peer-reviewed papers), leadership in clinical laboratory management, editorial contributions, and collaborative role in national cancer groups position him as a cornerstone of precision oncology in Switzerland and beyond.

๐ŸŽ“ Educationย 

Dr. Milo Frattiniโ€™s academic foundation began at the Scientific Lyceum of Milan, where he received a strong grounding in science. He pursued his undergraduate degree in Biology at the Universitร  degli Studi of Milan, graduating in 1998 with the highest distinction (110/110 cum laude). His thesis investigated calcium-dependent protein kinases in rice, reflecting his early interest in molecular biology. Building upon this foundation, Dr. Frattini later transitioned his focus toward human health and cancer research. In 2014, he earned a Ph.D. in Experimental Medicine and Oncology from the University of Insubria in Varese, Italy. His doctoral thesis explored the molecular characteristics of small bowel adenocarcinoma, aiming to identify novel therapeutic targets. His educational trajectory demonstrates a unique evolution from plant molecular biology to clinical oncology, establishing the multidisciplinary expertise that underpins his current contributions to molecular pathology and precision oncology.

๐Ÿงช Experience

Dr. Frattiniโ€™s professional journey began in 1999 as a Research Fellow at the Consiglio Nazionale delle Ricerche in Milan, where he studied calcium-dependent protein kinases. From 2000 to 2005, he expanded his expertise in cancer biology as a Research Fellow at the Istituto Nazionale dei Tumori in Milan, focusing on experimental molecular pathology. Since 2005, he has been leading the Laboratory of Molecular Pathology at the Institute of Pathology in Locarno, Switzerland. In this role, he oversees advanced molecular diagnostic workflows, contributing directly to clinical decision-making. Since 2008, he has also managed the instituteโ€™s quality control systems, ensuring diagnostic accuracy and compliance with international standards. With extensive laboratory leadership and hands-on clinical experience, Dr. Frattini plays a key role in integrating molecular diagnostics into routine cancer care. His dual expertise in laboratory science and clinical pathology places him at the forefront of translational oncology research in Switzerland.

๐Ÿ“ˆ Professional Development

Dr. Frattini has actively pursued professional development through editorial leadership, society memberships, and quality assurance roles. From 2010 to 2016, he served as Associate Editor of BMC Cancer, a prominent oncology journal. Since 2021, he has continued his editorial service with the Journal of Clinical Medicine, helping to guide scientific discourse in clinical research. He is a dedicated member of the Swiss Society of Pathology and the Swiss Group for Molecular Pathology, contributing to national standards in molecular diagnostics. Additionally, he participates in the SAKK Gastrointestinal and Lung Cancer Groups, which are instrumental in shaping Swiss clinical cancer trials. Dr. Frattini also holds the role of Head of Quality Control at his institute, ensuring laboratory processes meet stringent clinical and regulatory criteria. These roles demonstrate his commitment not only to research excellence but also to the development of best practices in molecular pathology, professional collaboration, and clinical innovation.

๐Ÿ”ฌ Research Focus

Dr. Frattiniโ€™s research focuses on the molecular characterization of solid tumors, with a particular emphasis on gastrointestinal and pulmonary cancers. His work aims to uncover the genomic and epigenetic alterations that drive tumor progression and treatment resistance. By integrating molecular profiling into diagnostic workflows, his research supports the personalization of cancer therapy. His Ph.D. work on small bowel adenocarcinomaโ€”a rare and under-researched cancerโ€”demonstrates his commitment to uncovering novel targets in hard-to-treat malignancies. He is also involved in studying molecular markers that predict patient response to targeted therapies and immunotherapies. Through collaborations with the SAKK groups, he contributes to clinical trial development and biomarker validation in real-world oncology settings. His translational research serves as a bridge between laboratory discoveries and bedside applications, significantly enhancing diagnostic precision and treatment outcomes in cancer care.

๐Ÿง  Research Skills

Dr. Frattini possesses a comprehensive skill set that spans molecular diagnostics, biomarker discovery, next-generation sequencing (NGS), and translational oncology. He is proficient in applying molecular biology techniquesโ€”such as PCR, DNA sequencing, and FISHโ€”to clinical pathology. His leadership of a molecular pathology laboratory involves the integration of high-throughput genomic analysis with traditional histopathology, optimizing tumor profiling for patient-specific treatments. He has experience in validating diagnostic assays for clinical use, ensuring both analytical sensitivity and specificity. His research also includes skillful design and interpretation of retrospective and prospective molecular studies, which inform therapeutic decisions in gastrointestinal and lung cancers. Additionally, his editorial and review work reflect advanced skills in scientific evaluation, literature synthesis, and methodological rigor. Dr. Frattiniโ€™s ability to combine technical expertise, clinical understanding, and quality control makes him an asset to the fields of precision medicine and oncology diagnostics.

๐Ÿ† Awards and Honors

While specific named awards are not listed in the CV, Dr. Milo Frattini’s career reflects numerous professional honors and responsibilities that underline his recognition in the scientific community. His long-standing editorial roles with BMC Cancer and Journal of Clinical Medicine indicate a high level of peer respect and scientific credibility. Being appointed as Head of both the Molecular Pathology Laboratory and Quality Control Division at the Institute of Pathology in Locarno is a significant institutional acknowledgment of his leadership and expertise. Furthermore, his membership in elite professional bodies such as the Swiss Group for Molecular Pathology, the Swiss Society of Pathology, and SAKK oncology groups points to his continued professional trust and influence. These roles, though not formal awards, collectively highlight Dr. Frattini’s impact, reliability, and sustained excellence in cancer research and molecular diagnostics.

Publication Top Notes

1. Neoโ€‘RAS Wild Type or RAS Conversion in Metastatic Colorectal Cancer: A Comprehensive Narrative Review

Citation: 2

Pesola, G., Epistolio, S., Cefalรฌ, M., Trevisi, E., De Dosso, S., & Frattini, M. (2024). Neoโ€‘RAS Wild Type or RAS Conversion in Metastatic Colorectal Cancer: A Comprehensive Narrative Review. Cancers, 16(23), 3923. https://doi.org/10.3390/cancers16233923 MDPIMDPIResearchGate

Summary:
This narrative review outlines the phenomenon of neoโ€‘RAS wildโ€‘type cancer, in which metastatic colorectal tumors originally harboring RAS mutations convert to wildโ€‘type status during or after chemotherapy. The proposed mechanisms include selective depletion of RASโ€‘mutant clones and expansion of preโ€‘existing RAS wildโ€‘type clones. The clinical implications concern eligibility for antiโ€‘EGFR therapies in converted patients, with potential survival benefits. The review emphasizes the need for liquid biopsy monitoring, improved detection techniques, and further validation of outcomes such as progressionโ€‘free and overall survival Nature+7PubMed+7ResearchGate+7.

2. Biomarker Characterization in Endometrial Cancer in Europe: First Survey Data Analysis from 69 Pathological Academic and Hospital Labs

Citation: 6

Santoro, A., Bragantini, E., Castiglione, F., etโ€ฏal. (2024). Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs. Pathologica, 116(1), 32โ€“45. https://doi.org/10.32074/1591โ€‘951Xโ€‘926 PubMedPMC

Summary:
This multicentric observational study surveyed 69 European pathology labs (academic and hospitalโ€based) across Italy, Spain, Switzerland, and the UK regarding practices in molecular biomarker testing for endometrial cancer. It reports variability in the routine use of immunohistochemistry (e.g., MMR, p53) and molecular testing (such as POLE), highlighting heterogeneity in adoption. Barriers such as resource limitations and lack of standardization were noted, indicating a need for Europeanโ€wide guidelines and more uniform workflows PubliRES+5PMC+5ResearchGate+5.

3. Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis

Citation: 4

Clinical relevance and interplay between miRNAs in influencing glioblastoma multiforme prognosis (2025). CMBL (review article). MDPIPubMedMDPI

Summary:
This recent narrative/review article discusses how specific microRNAs modulate gene networks influential in glioblastoma multiforme (GBM) progression and patient prognosis. It stresses GBM’s dismal median survival (~12โ€“15โ€ฏmonths) and explores key miRNAs such as miRโ€‘9 (oncogenic, associated with chemoresistance and poor survival), miRโ€‘221/222 (promoting proliferation, angiogenesis), and tumor-suppressive miRโ€‘181a/b. Emerging evidence around circulating miRโ€‘29a, miRโ€‘106a, and miRโ€‘200a as prognostic markers is also highlighted. The article proposes miRNA profiles as potential biomarkers and therapeutic targets in GBM management Nature.

4. Antiandrogens as Therapies for COVIDโ€‘19: A Systematic Review

Citation: 3

(2023). Antiandrogens as Therapies for COVIDโ€‘19: A Systematic Review. Included original studies through August 2023. ResearchGatePMC

Summary:
This systematic review (covering March 2020 to August 2023) evaluates the evidence for antiandrogenic therapiesโ€”including androgen-deprivation therapy (ADT), 5โ€‘alpha-reductase inhibitors, and antiandrogens like bicalutamide, enzalutamide, and proxalutamideโ€”in improving COVIDโ€‘19 outcomes. Of 31 studies screened, results were mixed: proxalutamide showed potential in accelerating viral clearance and reducing hospitalizations in benign severity cases, but large-scale randomized data are lacking. Conversely, trials of enzalutamide and bicalutamide failed to show therapeutic benefit and raised safety signalsโ€”โ€“bicalutamide is associated with increased mortality, particularly cardiovascular riskโ€”suggesting antiandrogens are not broadly effective as COVIDโ€‘19 treatments ScienceDirect+4ResearchGate+4PMC+4.

๐Ÿ Conclusion:

Dr. Milo Frattini exemplifies the qualities of an outstanding researcherโ€”scientific excellence, translational impact, clinical relevance, and leadership. His contributions significantly advance molecular pathology and personalized cancer treatment. In the absence of formal international awards, his sustained academic, clinical, and editorial responsibilities clearly reflect peer recognition and influence. He is highly suitable and strongly recommended for the Best Researcher Award.

Pinglin li | Marine Natural Products | Best Researcher Award

Posted on by The Scientist

Prof. Pinglin li | Marine Natural Products | Best Researcher Award

Professor at ocean university of China, China.

Dr. Li Pinglin is a distinguished professor at the School of Medicine and Pharmacy, Ocean University of China, with expertise in marine natural product chemistry. His research focuses on the isolation, structural elucidation, and bioactivity evaluation of secondary metabolites derived from marine invertebrates and their symbiotic microorganisms, especially from the South China Sea. He integrates advanced quantum chemical calculations such as ECD, NMR, and optical rotation analyses to decode complex molecular structures. With a prolific publication record in journals such as Marine Drugs, Phytochemistry, and Journal of Natural Products, Dr. Li has significantly contributed to the discovery of novel compounds with anti-inflammatory, anti-thrombotic, and cytotoxic properties. He has led several major national and provincial research projects and earned multiple scientific awards recognizing his innovative work. His academic journey is marked by a commitment to interdisciplinary research and excellence in marine-based pharmaceutical science.

Professional Profile:

ORCID

โœ…Suitability For Best Researcher Award – Prof. Pinglin li

Dr. Li Pinglin is a seasoned and internationally recognized marine natural product chemist whose research lies at the intersection of organic chemistry, pharmacology, and computational analysis. With over a decade of academic and research leadership at the Ocean University of China, and an extensive list of peer-reviewed publications and awards, he demonstrates excellence in scholarly output, innovation, mentorship, and societal relevance. His continuous research support from national agencies and international exposure (e.g., Scripps Institution of Oceanography) strengthens his global profile.

๐ŸŽ“ Education

Dr. Li Pinglin earned his Ph.D. in Organic Chemistry in 2008 from Lanzhou University, China, one of the country’s top institutions in chemical sciences. Prior to this, he completed his Bachelor of Science in Chemistry in 2003 at the same university. His educational background laid a solid foundation in organic synthesis, molecular structure elucidation, and analytical chemistry. Dr. Li also broadened his scientific outlook through international academic exchange, serving as a visiting scholar at the prestigious Scripps Institution of Oceanography, University of California, San Diego, from 2015 to 2016, where he engaged in marine pharmacology and natural product chemistry.

๐Ÿ’ผ Experience

Dr. Li Pinglin has had a progressive academic career at the Ocean University of China. He began as a lecturer in the College of Food Science and Engineering (2008โ€“2011) before transitioning to the School of Medicine and Pharmacy, where he served as a lecturer (2011โ€“2013), associate professor (2014โ€“2015), and has held the position of professor since January 2016. His long-standing affiliation with the university reflects deep institutional knowledge and leadership. He has supervised numerous graduate students and has contributed significantly to the growth of research in marine pharmacology, establishing himself as a core figure in the faculty’s scientific development.

๐Ÿ“ˆ Professional Development

Throughout his career, Dr. Li has consistently advanced both his scientific expertise and professional influence. His research has been supported by prestigious funding bodies, including the National Natural Science Foundation of China and the Shandong Province Funds for Distinguished Young Scientists. As a chief investigator, he has led multiple competitive research projects and contributed to China’s growing leadership in marine bioprospecting. His professional development was further enriched during his tenure as a visiting scholar at the Scripps Institution of Oceanography, UCSD, where he engaged with global leaders in marine chemistry. Dr. Li has fostered interdisciplinary collaboration through his work on quantum-based stereochemical analysis and semi-synthesis of bioactive compounds. His publication record and award-winning contributions reflect continuous growth in scholarly impact and recognition. He remains committed to mentoring emerging scientists and contributing to the advancement of marine pharmacological sciences on both national and international fronts.

๐Ÿ”ฌ Research Focus

Dr. Li Pinglinโ€™s primary research focus lies within Marine Natural Product Chemistryโ€”an interdisciplinary field combining marine biology, organic chemistry, and pharmacology. His work involves the discovery, isolation, and structural characterization of secondary metabolites from South China Sea marine invertebrates, particularly soft corals and sponge-associated microorganisms. These natural compounds often display potent bioactivities, including anti-inflammatory, anti-thrombotic, cytotoxic, and antimicrobial effects, offering potential for pharmaceutical development. Dr. Liโ€™s research also encompasses semi-synthetic modifications to enhance compound efficacy and stability. Additionally, his focus extends into computational chemistry, applying quantum methods such as ECD and NMR simulation to verify stereochemistry and chiral centers. This category of research plays a critical role in drug discovery, chemical ecology, and biomedical innovation. By bridging field exploration with molecular-level analysis, Dr. Liโ€™s work contributes to unlocking the therapeutic potential of marine biodiversity and supporting sustainable marine drug development.

๐Ÿงช Research Skills

Dr. Li possesses a specialized skill set in natural product chemistry, particularly related to marine-derived compounds. His skills include advanced chromatographic isolation techniques (e.g., HPLC, LC-MS), spectroscopic structure elucidation (e.g., NMR, MS, IR), and quantum chemical calculations (e.g., ECD, NMR shift prediction, optical rotation) for stereochemical determination. He is adept at utilizing nuclear Overhauser effect spectroscopy (NOESY) and residual dipolar couplings (RDCs) to resolve challenging macrocyclic structures. Additionally, Dr. Li engages in semi-synthetic derivatization, enhancing the pharmaceutical potential of marine metabolites. His research relies on bioassay-guided fractionation, enabling targeted screening for anti-inflammatory, cytotoxic, and anti-thrombotic activities. He combines wet lab precision with computational chemistry to achieve accurate and efficient structural verification. These interdisciplinary skills are essential for modern drug discovery pipelines and chemical biology research, making Dr. Li a valuable expert at the intersection of marine science, organic chemistry, and medicinal chemistry.

๐Ÿ… Awards and Honors

Dr. Li Pinglin has received several prestigious awards in recognition of his outstanding research contributions. Notably, he was honored with the Sanofi Biopharmaceuticals Award for Youth by the Chinese Pharmaceutical Association in 2013, acknowledging his early-career excellence in drug-related research. He has also received multiple international academic awards from Sciencefarther and Scifax, India, including the Best Research Award from the 21st ACA Edition, Top Teachers Award in its 9th edition (TOT), and the Best Research Award in Advanced Nanomaterials and Nanotechnology (14th ANN Edition). These accolades highlight both his scientific innovation and teaching excellence, demonstrating national and global recognition. His award record affirms his sustained impact in natural product chemistry and his leadership in advancing marine-based therapeutic research.

Publication Top Notes

๐Ÿงช 1. Discovery of Secondary Metabolites from the Sponge-Derived Fungus Aspergillus templicola

  • Journal: Marine Drugs

  • Date: July 2025

  • DOI: 10.3390/md23070285

  • Authors: Kai Li, Yue Zhang, Lei Li, Sen Wang, Cili Wang, Pinglin Li

  • Summary:
    This study reports the isolation and structural elucidation of novel secondary metabolites from the sponge-associated fungus Aspergillus templicola. The research highlights their potential biological activities, including antimicrobial and cytotoxic properties, demonstrating marine fungi as promising sources of bioactive natural products.

๐Ÿงฌ 2. Heterocycles and a Sorbicillinoid from the Coral-Derived Fungus Penicillium chrysogenum

  • Journal: Marine Drugs

  • Date: November 2024

  • DOI: 10.3390/md22110517

  • Authors: Junjie Yang, Yuan Zong, Cili Wang, Kai Li, Yue Zhang, Pinglin Li

  • Citation: 8 citations

  • Summary:
    This paper explores the chemical diversity of Penicillium chrysogenum isolated from coral. It features the discovery of novel heterocyclic compounds and a sorbicillinoid derivative. Bioassays revealed antimicrobial and cytoprotective properties, highlighting their pharmacological relevance.

๐ŸŒŠ 3. Terpenoids from the Soft Coral Sinularia densa Collected in the South China Sea

  • Journal: Marine Drugs

  • Date: September 2024

  • DOI: 10.3390/md22100442

  • Authors: Cili Wang, Jiarui Zhang, Kai Li, Junjie Yang, Lei Li, Sen Wang, Hu Hou, Pinglin Li

  • Citation: 2 citations

  • Summary:
    The study identifies a series of terpenoid compounds from Sinularia densa, a soft coral species. Structural analysis and biological assays suggest these terpenoids exhibit promising bioactivities, especially in anti-inflammatory and anticancer screening platforms.

๐Ÿงด 4. Lemneolemnanes Aโ€“D, Four Uncommon Sesquiterpenoids from the Soft Coral Lemnalia sp.

  • Journal: Marine Drugs

  • Date: March 2024

  • DOI: 10.3390/md22040145

  • Authors: Yuan Zong, Tian-Yun Jin, Jun-Jie Yang, Kun-Ya Wang, Xing Shi, Yue Zhang, Pinglin Li

  • Citation: 1 citation

  • Summary:
    This article presents the isolation of four novel sesquiterpenoids named Lemneolemnanes Aโ€“D from Lemnalia species. The structural uniqueness and cytotoxic potential of these compounds reinforce the chemical richness of marine soft corals.

Conclusion

Dr. Li Pinglin exemplifies the ideals of a Best Researcher Award recipient. His innovative contributions to marine pharmacological sciences, especially his work in discovering and analyzing bioactive marine natural products, not only advance scientific understanding but also hold translational potential for human health. His blend of technical skill, research productivity, mentorship, and global recognition makes him a top-tier candidate deserving of the Best Researcher Award.

Julia Krebs | Sign Language Linguistics | Best Researcher Award

Posted on by The Scientist

Assist. Prof. Dr. Julia Krebs | Sign Language Linguistics | Best Researcher Award

Assistant professor at University of Salzburg, Austria.

Dr. Julia Krebs ๐ŸŽ“ is an Assistant Professor in the Department of Linguistics at the University of Salzburg ๐Ÿ‡ฆ๐Ÿ‡น, where she specializes in psycho-/neurolinguistics and sign language linguistics ๐Ÿง ๐Ÿ‘. She began her academic journey with certification as an Austrian Sign Language (ร–GS) interpreter, gaining practical insights that now shape her research. Dr. Krebs is known for pioneering work on the neural processing of sign language using EEG and motion capture techniques ๐Ÿ“Š๐ŸŽฅ. She has published over 20 peer-reviewed articles ๐Ÿ“š, co-authored a definitive handbook on ร–GS grammar ๐Ÿ“˜, and leads two Austrian Science Fund (FWF)-funded projects. Her interdisciplinary contributions span linguistics, cognitive neuroscience, and accessibility, promoting educational tools and enhancing societal recognition for sign language communities ๐ŸŒ๐Ÿ‘ฉโ€๐Ÿซ. Collaborating with international scholars, her work significantly advances the theoretical and applied understanding of ร–GS. She is a rising leader in sign linguistics and cognitive processing research ๐Ÿ†๐ŸŒ.

Professional Profile:

Scopus

ORCID

Google Scholar

Suitability For Best Researcher Award – Assist. Prof. Dr. Julia Krebs

Dr. Julia Krebs stands out as a rising leader in interdisciplinary linguistic research. Her unique combination of practical experience as a certified Austrian Sign Language (ร–GS) interpreter and her academic training in psycho-/neurolinguistics equips her to bridge theoretical insights with community needs. As an Assistant Professor, she has already made significant strides in applied research, neural processing of sign language, and educational accessibility. Her leadership in FWF-funded projects, her pioneering use of EEG and motion capture, and her substantial publication record demonstrate a strong and sustained research trajectoryโ€”especially remarkable at an early career stage.

๐ŸŽ“ Education

Dr. Krebs holds a Ph.D. in Psycho-/Neurolinguistics ๐Ÿง ๐Ÿ“– from the University of Salzburg, where she continues her academic career. Her educational foundation is uniquely interdisciplinaryโ€”blending theoretical linguistics ๐Ÿ“š, cognitive neuroscience ๐Ÿงฌ, and practical communication through her formal certification as an Austrian Sign Language (ร–GS) interpreter ๐Ÿ‘๐Ÿ‡ฆ๐Ÿ‡น. This rare combination allows her to approach linguistic research from both empirical and experiential perspectives, integrating scientific rigor with community-centered insight. Her academic training empowers her to bridge the gap between language theory and applied research in the context of neurocognitive processing and sign language acquisition ๐ŸŽ“๐Ÿ”.

๐Ÿง‘โ€๐Ÿซ Experience

Dr. Julia Krebs serves as an Assistant Professor at the University of Salzburg’s Department of Linguistics ๐Ÿซ๐Ÿ“š. She has accumulated substantial experience in both teaching and research, focusing on sign language grammar, acquisition, and processing ๐Ÿง โœ๏ธ. With roots as a professional ร–GS interpreter, she has a decade-long immersion in both practice and academia ๐Ÿ‘๐Ÿ‘ฉโ€๐ŸŽ“. Dr. Krebs has successfully led and collaborated on several major research projects, including EEG-based studies and motion capture investigations into sign language production ๐ŸŽฅ๐Ÿ’ป. She works closely with international scholars and has contributed to curriculum development, interpreter education, and pedagogical strategies. Her contributions extend beyond research to real-world applications that empower the Deaf community and language educators alike ๐ŸŒ๐Ÿ‘ฉโ€๐Ÿซ.

๐Ÿš€ Professional Developmentย 

Dr. Krebs continually enriches her professional growth through advanced research collaborations, project leadership, and interdisciplinary integration ๐ŸŒ๐Ÿ”ฌ. She spearheads two major projects funded by the Austrian Science Fund (FWF), applying innovative techniques like motion capture and electromyography (EMG) to study sign language production ๐ŸŽฅโšก. A proactive member of academic societies including the Sign Language Linguistics Society (SLLS) and the Centre for Cognitive Neuroscience (CCNS) ๐Ÿง ๐ŸŒ, she stays at the forefront of emerging research. Dr. Krebs also engages in public science communication through co-authoring a seminal ร–GS grammar handbook and developing accessible educational materials ๐Ÿ“˜๐Ÿ“ข. Her professional path demonstrates a strong commitment to both advancing theoretical knowledge and fostering inclusive language education. As an early-career academic, she is building a global reputation through interdisciplinary research, co-authorship, and peer-reviewed publications ๐Ÿ“š๐Ÿค, paving the way for future leadership in linguistics and cognitive science.

๐Ÿ” Research Focus

Dr. Julia Krebsโ€™s research focus lies at the intersection of sign language linguistics, cognitive neuroscience, and language acquisition ๐Ÿง ๐Ÿ‘๐Ÿ“˜. Her primary domain is Austrian Sign Language (ร–GS), where she investigates grammar structures, agreement markers, and word order through both theoretical and experimental approaches ๐Ÿงช๐Ÿ“Š. A notable aspect of her work is the use of dynamic EEG experiments and motion capture to study how the brain processes and produces sign language stimuli ๐ŸŽฅโšก. Her studies provide critical insights into how signed and spoken languages share cognitive mechanisms, like subject-preference in sentence processing ๐Ÿ—ฃ๏ธ๐Ÿง . She also emphasizes how this scientific knowledge can improve language instruction and interpreter training, fostering accessibility and cultural recognition for the Deaf community ๐Ÿงโ€โ™€๏ธ๐Ÿ“š. Dr. Krebs’s research contributes both to the foundational understanding of human language and to applied linguistics, making her focus both innovative and socially impactful ๐Ÿ’ก๐ŸŒ.

๐Ÿง Research Skills

Dr. Krebs is equipped with a powerful set of research skills spanning neurolinguistics, psycholinguistics, sign language analysis, and computational methodology ๐Ÿ”ฌ๐Ÿ“Š. She excels in the design and execution of EEG experiments to study neural responses to linguistic stimuli ๐Ÿง ๐Ÿ’ก. Additionally, she leverages motion capture and EMG to explore sign language production in real time, a rare and highly technical approach ๐ŸŽฅโšก. Her analytical expertise covers both quantitative and qualitative data interpretation, especially in syntactic and semantic analysis of ร–GS ๐Ÿ“ˆ๐Ÿ“š. As a co-author of a grammar handbook, she demonstrates deep descriptive and applied linguistic competence. Her collaborative skills are also keyโ€”she effectively manages cross-disciplinary and international research teams ๐Ÿค๐ŸŒ. Combined with strong academic writing and publication ability, Dr. Krebsโ€™s toolkit enables her to make robust contributions to both theoretical and applied linguistics, helping to elevate the field of sign language linguistics globally ๐Ÿš€โœ๏ธ.

๐Ÿ†Awards and Honors

Dr. Julia Krebs was honored with the Young Investigator Award ๐ŸŽ–๏ธ by the University of Salzburg, recognizing her outstanding early-career achievements in linguistic research. Her co-authorship of the first comprehensive grammar handbook on Austrian Sign Language (ร–GS) ๐Ÿ“˜ was a landmark contribution to the field and has received national acclaim for its academic and social value ๐Ÿ“š๐Ÿ…. In addition to this prestigious institutional recognition, her leadership in FWF-funded research projects demonstrates her scholarly merit and research credibility at the national level ๐Ÿ‡ฆ๐Ÿ‡น๐Ÿ’ผ. Her groundbreaking work has gained attention in the scientific community and continues to earn accolades for its impact on both academia and the Deaf community ๐Ÿงโ€โ™€๏ธ๐Ÿ’ฌ๐ŸŒŸ.

Publication Top Notes

1. Age of acquisition effects differ across linguistic domains in sign language: EEG evidence

๐Ÿ“Œ Authors: E.A. Malaia, J. Krebs, D. Roehm, R.B. Wilbur
๐Ÿ“… Journal: Brain and Language, Vol. 200, 2020, Article 104708
๐Ÿ“ˆ Citations: 31
๐Ÿ” Summary:
This study uses EEG (electroencephalography) to examine how the age of acquisition (AoA) of sign language impacts neural processing across different linguistic domains. The findings show that early and late learners of sign language exhibit significantly different neural responses when processing syntax, semantics, and morpho-syntactic elements, indicating that AoA has domain-specific effects on language processing in the brain.
๐Ÿง  Contribution: First electrophysiological evidence supporting domain-specific AoA effects in sign language users.

2. Subject preference emerges as cross-modal strategy for linguistic processing

๐Ÿ“Œ Authors: J. Krebs, E. Malaia, R.B. Wilbur, D. Roehm
๐Ÿ“… Journal: Brain Research, Vol. 1691, 2018, Pages 105โ€“117
๐Ÿ“ˆ Citations: 30
๐Ÿ” Summary:
This paper explores the “subject preference” strategy โ€” the tendency to interpret ambiguous sentences as having a subject-first structure โ€” in both spoken and signed languages. Using EEG, the study demonstrates that this strategy is a cross-modal linguistic feature, not limited to spoken languages, and applies to sign language as well.
๐Ÿง  Contribution: Supports the theory that certain parsing strategies are modality-independent, reflecting universal cognitive-linguistic principles.

3. Age of sign language acquisition has lifelong effect on syntactic preferences in sign language users

๐Ÿ“Œ Authors: J. Krebs, D. Roehm, R.B. Wilbur, E.A. Malaia
๐Ÿ“… Journal: International Journal of Behavioral Development, Vol. 45(5), 2021, Pages 397โ€“408
๐Ÿ“ˆ Citations: 22
๐Ÿ” Summary:
This behavioral study investigates how AoA influences syntactic preferences in adult sign language users. Findings suggest that early exposure leads to more native-like preferences for canonical word order, whereas later learners demonstrate alternative syntactic strategies.
๐Ÿง  Contribution: Emphasizes the long-term syntactic impact of AoA in signed languages, with implications for education and cognitive development in deaf individuals.

4. Interaction between topic marking and subject preference strategy in sign language processing

๐Ÿ“Œ Authors: J. Krebs, E. Malaia, R.B. Wilbur, D. Roehm
๐Ÿ“… Journal: Language, Cognition and Neuroscience, Vol. 35(4), 2020, Pages 466โ€“484
๐Ÿ“ˆ Citations: 18
๐Ÿ” Summary:
This research explores how topic marking interacts with the subject preference parsing strategy in sign language. Using EEG, the study shows that topic marking can override the default subject-first strategy, demonstrating the dynamic nature of syntactic processing in sign language.
๐Ÿง  Contribution: Offers insights into hierarchical cue processing and discourse-level structure in signed languages.

5. The impact of transitional movements and non-manual markings on the disambiguation of locally ambiguous argument structures in Austrian Sign Language (ร–GS)

๐Ÿ“Œ Authors: J. Krebs, R.B. Wilbur, P.M. Alday, D. Roehm
๐Ÿ“… Journal: Language and Speech, Vol. 62(4), 2019, Pages 652โ€“680
๐Ÿ“ˆ Citations: 17
๐Ÿ” Summary:
This paper investigates how non-manual cues (e.g., facial expressions) and transitional hand movements help disambiguate syntactic ambiguity in Austrian Sign Language. Results show that signers rely heavily on these multimodal features for parsing sentence structure.
๐Ÿง  Contribution: Highlights the role of multimodal information in syntactic disambiguation and emphasizes the complexity of visual-spatial grammar.

Conclusionย 

Dr. Julia Krebs exemplifies the profile of a Best Researcher Award recipient: innovative, impactful, interdisciplinary, and community-engaged. Her scientific work not only advances core knowledge in neurolinguistics and sign language linguistics but also translates into real-world benefitsโ€”educationally, socially, and technologically. She is not only contributing to academia but also reshaping how we understand and support sign language users in society.